Literature DB >> 14627359

Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease.

I Morgenstern1, M T M Raijmakers, W H M Peters, H Hoensch, W Kirch.   

Abstract

The present study was performed to evaluate the levels of the amino thiols cysteine, homocysteine, and glutathione in the colonic mucosa of patients with various intestinal diseases, especially chronic inflammatory bowel disease. Colonic biopsies of macroscopically normal mucosa out of a proximal and distal segment were collected from 187 patients with various intestinal diseases. Protein was assayed in duplicate by the method of Lowry et al (1951), using bovine serum albumin as standard. Total glutathione, cysteine, and homocysteine were quantified by high performance liquid chromatography (HPLC) with fluorescent detection. Only in patients with inflammatory bowel disease were the homocysteine levels in the large bowel mucosa significantly elevated compared with the concentrations in patients with normal mucosa. No significant differences were seen for glutathione and cysteine concentrations in colonic mucosa among the different groups of diseases. No correlation was found between the age of the patients and levels of the amino thiols investigated. GSH content and concentrations of cysteine and homocysteine were similar in male and female subjects. In our study markedly elevated concentrations of homocysteine in the colonic mucosa were observed in patients suffering from ulcerative colitis and Crohn's disease. This finding has been reported already in the literature for plasma homocysteine levels. Increased homocysteine levels in the colonic mucosa and plasma of patients with inflammatory bowel disease may play a role in the pathogenesis of Crohn's disease and ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627359     DOI: 10.1023/a:1026338812708

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

Review 1.  Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.

Authors:  C D Stehouwer; C Jakobs
Journal:  Eur J Pediatr       Date:  1998-04       Impact factor: 3.183

2.  Plasma thiol status in preeclampsia.

Authors:  M T Raijmakers; P L Zusterzeel; E A Steegers; M P Hectors; P N Demacker; W H Peters
Journal:  Obstet Gynecol       Date:  2000-02       Impact factor: 7.661

3.  Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis.

Authors:  M Krogh Jensen; S Ekelund; L Svendsen
Journal:  Scand J Clin Lab Invest       Date:  1996-08       Impact factor: 1.713

4.  The influence of dietary folate and methionine on the metabolic disposition of endotoxic homocysteine.

Authors:  M D Lucock; I G Daskalakis; J Wild; A Anderson; C J Schorah; M E Lean; M I Levene
Journal:  Biochem Mol Med       Date:  1996-12

Review 5.  Homocysteine: cholesterol of the 90s?

Authors:  L J Langman; D E Cole
Journal:  Clin Chim Acta       Date:  1999-08       Impact factor: 3.786

6.  High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?

Authors:  M Cattaneo; M Vecchi; M L Zighetti; S Saibeni; I Martinelli; P Omodei; P M Mannucci; R de Franchis
Journal:  Thromb Haemost       Date:  1998-10       Impact factor: 5.249

Review 7.  Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system.

Authors:  P M Ueland; M A Mansoor; A B Guttormsen; F Müller; P Aukrust; H Refsum; A M Svardal
Journal:  J Nutr       Date:  1996-04       Impact factor: 4.798

Review 8.  Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.

Authors:  M H Moghadasian; B M McManus; J J Frohlich
Journal:  Arch Intern Med       Date:  1997-11-10

Review 9.  Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review.

Authors:  M R Malinow
Journal:  Clin Chem       Date:  1995-01       Impact factor: 8.327

10.  Folic acid responsive postmenopausal homocysteinemia.

Authors:  L E Brattström; B L Hultberg; J E Hardebo
Journal:  Metabolism       Date:  1985-11       Impact factor: 8.694

View more
  17 in total

1.  p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.

Authors:  Hala E Hamouda; Soha S Zakaria; Saber A Ismail; Mahmoud A Khedr; Wael W Mayah
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Sabri Batun; Abdullah Altintaş
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

Review 3.  Radical induction theory of ulcerative colitis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

Review 4.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

5.  Increased levels of homocysteine in patients with ulcerative colitis.

Authors:  Sabiye Akbulut; Emin Altiparmak; Firdevs Topal; Ersan Ozaslan; Metin Kucukazman; Ozlem Yonem
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

6.  Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells.

Authors:  Young-Mi Go; Thomas R Ziegler; Jennifer M Johnson; Li Gu; Jason M Hansen; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2006-11-10       Impact factor: 7.376

7.  MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer.

Authors:  Yvonne Wettergren; Elisabeth Odin; Göran Carlsson; Bengt Gustavsson
Journal:  Mol Med       Date:  2010-06-11       Impact factor: 6.354

8.  A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?

Authors:  Valérie Marcil; Emile Levy; Devendra Amre; Alain Bitton; Ana Maria Guilhon de Araújo Sant'Anna; Andrew Szilagy; Daniel Sinnett; Ernest G Seidman
Journal:  Inflamm Bowel Dis       Date:  2019-07-17       Impact factor: 5.325

9.  B-vitamin deficiency is protective against DSS-induced colitis in mice.

Authors:  Nancy M Benight; Barbara Stoll; Shaji Chacko; Vanessa R da Silva; Juan C Marini; Jesse F Gregory; Sally P Stabler; Douglas G Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-05-19       Impact factor: 4.052

10.  Methylenetetrahydrofolate reductase C677T gene polymorphism and colorectal cancer risk: A case-control study.

Authors:  Guancheng Yin; Hanxin Ming; Xiao Zheng; Yi Xuan; Jianwei Liang; Xing Jin
Journal:  Oncol Lett       Date:  2012-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.